Moreover, the increased GSL-II binding to integrins β1 and α6 caused by B4GALT1 knockout was almost completely blocked (Fig. 4C, D), suggesting that B4GALT1 predominantly modified the N-glycans of integrins β1 and α6 in HCC cells. Here, B4GALT1 is linked to hepatocellular carcinoma.